EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieKohortenstudieOpen Access · CC BY 4.0

Perinatal outcomes after selective third‐trimester ultrasound screening for small‐for‐gestational age: prospective cohort study nested within DESiGN randomized controlled trial

C Winsloe iD, J Elhindi, M C Vieira, S Relph, C G Arcus, K Coxon, A Briley, M Johnson, L M Page, A Shennan, N Marlow, C Lees iD und 6 weitere

Ultrasound in Obstetrics & Gynecology · 2025-01 · 65 (1) · 30-38

DOI: 10.1002/uog.29130 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Ultrasound in Obstetrics & Gynecology, online erschienen am 25.11.2024. Verfasst von C Winsloe und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Women and Children's Health, School of Life Course and Population Sciences, Faculty of Life Sciences and Medicine, King's College Londo…. Hauptthemen laut MEDLINE: Infant, Small for Gestational Age, Pregnancy Outcome, Pregnancy Trimester, Third, Ultrasonography, Prenatal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tommy's Baby Charity, Stillborn and Neonatal Death Charity, Guy's & St Thomas' Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

In screening for small‐for‐gestational age ( SGA ) using third‐trimester antenatal ultrasound, there are concerns about the low detection rates and potential for harm caused by both false‐negative and false‐positive screening results. Using a selective third‐trimester ultrasound screening program, this study aimed to investigate the incidence of adverse perinatal outcomes among cases with (i) false‐negative compared with true‐positive SGA diagnosis and (ii) false‐positive compared with true‐negative SGA diagnosis.

Methods

This prospective cohort study was nested within the UK ‐based DESiGN trial, a prospective multicenter cohort study of singleton pregnancies without antenatally detected fetal anomalies, born at > 24 + 0 to < 43 + 0 weeks' gestation. We included women recruited to the baseline period, or control arm, of the trial who were not exposed to the Growth Assessment Protocol intervention and whose birth outcomes were known. Stillbirth and major neonatal morbidity were the two primary outcomes. Minor neonatal morbidity was considered a secondary outcome. Suspected SGA was defined as an estimated fetal weight ( EFW ) < 10 th percentile, based on the Hadlock formula and fetal growth charts. Similarly, SGA at birth was defined as birth weight ( BW ) < 10 th percentile, based on UK population references. Maternal and pregnancy characteristics and perinatal outcomes were reported according to whether SGA was suspected antenatally or not. Unadjusted and adjusted logistic regression models were used to quantify the differences in adverse perinatal outcomes between the screening results (false negative vs true positive and false positive vs true negative).

Results

In total, 165 321 pregnancies were included in the analysis. Fetuses with a false‐negative SGA screening result, compared to those with a true‐positive result, were at a significantly higher risk of stillbirth (adjusted odds ratio ( aOR ), 1.18 (95% CI , 1.07–1.31)), but at lower risk of major ( aOR , 0.87 (95% CI , 0.83–0.91)) and minor ( aOR , 0.56, (95% CI , 0.54–0.59)) neonatal morbidity. Compared with a true‐negative screening result, a false‐positive result was associated with a lower BW percentile (median, 18.1 (interquartile range ( IQR ), 13.3–26.9) vs 49.9 ( IQR , 30.3–71.7)). A false‐positive result was also associated with a significantly increased risk of stillbirth ( aOR , 2.24 (95% CI , 1.88–2.68)) and minor neonatal morbidity ( aOR , 1.60 (95% CI , 1.51–1.71)), but not major neonatal morbidity ( aOR , 1.04 (95% CI , 0.98–1.09)).

Conclusions

In selective third‐trimester ultrasound screening for SGA , both false‐negative and false‐positive results were associated with a significantly higher risk of stillbirth, when compared with true‐positive and true‐negative results, respectively. Improved SGA detection is needed to address false‐negative results. It should be acknowledged that cases with a false‐positive SGA screening result also constitute a high‐risk population of small fetuses that warrant surveillance and timely birth. © 2024 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Infant, Small for Gestational AgePregnancy OutcomePregnancy Trimester, ThirdUltrasonography, PrenatalPrenatal DiagnosisAdultFemaleHumansInfant, NewbornPregnancyFalse Negative ReactionsFalse Positive ReactionsFetal Growth RetardationGestational AgeProspective StudiesStillbirthUnited KingdomCohort Studies

Stichwörter der Autor:innen

antenatal diagnosiscerebral intraventricular hemorrhagefetal deathfetal growth restrictionfetal weighthypoxia–ischemia, brainmissed diagnosisperinatal mortalitypregnancy complicationsprenatal ultrasonography

Autor:innen und Institutionen

  • Department of Women and Children's Health, School of Life Course and Population Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Centre for Pragmatic Global Health Trials, Institute for Global Health, University College London, London, UK.
  • The Reproduction and Perinatal Centre, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
  • Department of Obstetrics and Gynecology, University of Campinas (UNICAMP), School of Medical Sciences, São Paulo, Brazil.
  • Women's Health Division, Royal London Hospital, Barts Health NHS Trust, London, UK.
  • School of Nursing and Midwifery, University of Central Lancashire, Preston, UK.

ORCID-Profile: C Winsloe, C Lees, A Khalil

Förderung

  • Tommy's Baby Charity
  • Stillborn and Neonatal Death Charity
  • Guy's & St Thomas' Foundation
  • Medical Research Council
  • British Heart Foundation

Zitieren

APA

Winsloe, C., Elhindi, J., Vieira, M. C., Relph, S., Arcus, C. G., Coxon, K., Briley, A., Johnson, M., Page, L. M., Shennan, A., Marlow, N., Lees, C., Lawlor, D. A., Khalil, A., Sandall, J., Copas, A., Pasupathy, D., & DESiGN Trial Team (2025). Perinatal outcomes after selective third‐trimester ultrasound screening for small‐for‐gestational age: prospective cohort study nested within DESiGN randomized controlled trial. Ultrasound in Obstetrics & Gynecology, 65(1), 30-38. https://doi.org/10.1002/uog.29130

Vancouver

Winsloe C, Elhindi J, Vieira MC, Relph S, Arcus CG, Coxon K, et al. Perinatal outcomes after selective third‐trimester ultrasound screening for small‐for‐gestational age: prospective cohort study nested within DESiGN randomized controlled trial. Ultrasound in Obstetrics & Gynecology. 2025;65(1):30-38. doi:10.1002/uog.29130

BibTeX
@article{Winsloe2025,
  author = {Winsloe, C and Elhindi, J and Vieira, M C and Relph, S and Arcus, C G and Coxon, K and Briley, A and Johnson, M and Page, L M and Shennan, A and Marlow, N and Lees, C and Lawlor, D A and Khalil, A and Sandall, J and Copas, A and Pasupathy, D and DESiGN Trial Team, DESiGN Trial Team},
  title = {Perinatal outcomes after selective third‐trimester ultrasound screening for small‐for‐gestational age: prospective cohort study nested within DESiGN randomized controlled trial},
  journal = {Ultrasound in Obstetrics & Gynecology},
  year = {2025},
  volume = {65},
  number = {1},
  pages = {30--38},
  doi = {10.1002/uog.29130}
}
Kostenlos starten →